Industry Roundup: Zantac 150 Choices, Nature's Health Warning
This article was originally published in The Tan Sheet
Executive Summary
More Zantac 150 choices; Nature's Health warned on claims, GMPs; Marine Ingredients adds Swiss Caps plant; and more news in brief.
You may also be interested in...
Health, Beauty And Wellness Transaction News: SlimFast To Glanbia, More MedMen Moves, Empower Production Partner
Glanbia adds SlimFast to its lineup; MedMen making moves in cannabis market; and production partner for Empower medical cannabis.
Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap
A pending agreement includes a $5.2bn cash payment from Boehringer to Sanofi but excludes Boehringer’s consumer product business in China. The brands Sanofi will add to its consumer health lineup include two marketed in the US, Dulcolax constipation relief and Zantac heartburn remedy.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.